Penelope Gray

About me
Publications
CV
Public outreach and news

About me

PhD in epidemiology, Tampere University
MSc in health Sciences (Public Health), University of Tampere
BSc with honours in biological sciences (infectious diseases), The University
of Edinburgh

Articles

Article: INTERNATIONAL JOURNAL OF CANCER. 2024;155(9):1549-1557
Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesions
Louvanto K; Verhoef L; Pimenoff V; Eriksson T; Leppala S; Lagheden C; Gray P; Scibior-Bentkowska D; Sumiec E; Nieminen P; Dillner J; Berkhof J; Meijer CJLM; Lehtinen M; Nedjai B; Heideman DAM
Journal article: NPJ VACCINES. 2024;9(1):146
Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study
Gray P; Mariz FC; Eklund C; Eriksson T; Faust H; Kann H; Mueller M; Paavonen J; Pimenoff VN; Sehr P; Surcel H-M; Dillner J; Waterboer T; Lehtinen M
Article: INTERNATIONAL JOURNAL OF CANCER. 2024;154(9):1537-1548
Scientific approaches toward improving cervical cancer elimination strategies
Lehtinen M; Bruni L; Elfstrom M; Gray P; Logel M; Mariz FC; Baussano I; Vanska S; Franco EL; Dillner J
Article: PLOS ONE. 2024;19(7):e0305285
Seroepidemiological assessment of the spread of SARS-CoV-2 among 25 and 28 year-old adult women in Finland between March 2020-June 2022
Gray P; Eriksson T; Skoglund L; Lagheden C; Hellstrom C; Pin E; Suomenrinne-Nordvik A; Pimenoff VN; Nilsson P; Dillner J; Lehtinen M
Article: ELIFE. 2023;12:e80905
Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic
Elfstrom M; Gray PG; Dillner J
Article: CELL HOST AND MICROBE. 2023;31(11):1921-1929.e3
Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts
Pimenoff VN; Gray P; Louvanto K; Eriksson T; Lagheden C; Soderlund-Strand A; Dillner J; Lehtinen M
Article: JOURNAL OF INFECTIOUS DISEASES. 2022;226(7):1195-1199
Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses
Arroyo Muhr LS; Eklund C; Lagheden C; Eriksson T; Pimenoff VN; Gray P; Lehtinen M; Dillner J
Article: BMJ OPEN. 2021;11(12):e050669
Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial
Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Bly A; Gray P; Harjula K; Heikkila K; Hokkanen M; Karttunen H; Kuortti M; Nieminen P; Nummela M; Paavonen J; Palmroth J; Petaja T; Pukkala E; Soderlund-Strand A; Veivo U; Dillner J
Article: THE LANCET INFECTIOUS DISEASES. 2021;21(10):1458-1468
Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials
Mariz FC; Gray P; Render N; Eriksson T; Kann H; Apter D; Paavonen J; Pajunen E; Prager KM; Sehr P; Surcel H-M; Waterboer T; Mueller M; Pawlita M; Lehtinen M
Article: PLOS MEDICINE. 2021;18(6):e1003588
Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial
Gray P; Kann H; Pimenoff VN; Eriksson T; Luostarinen T; Vanska S; Surcel H-M; Faust H; Dillner J; Lehtinen M
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;147(12):3511-3522
Long-term follow-up of human papillomavirus type replacement among young pregnant Finnish females before and after a community-randomisedHPVvaccination trial with moderate coverage
Gray P; Kann H; Pimenoff VN; Adhikari I; Eriksson T; Surcel H-M; Vanska S; Dillner J; Faust H; Lehtinen M
Article: INTERNATIONAL JOURNAL OF CANCER. 2020;147(2):440-447
Baseline findings and safety of infrequent vs. frequent screening of human papillomavirus vaccinated women
Louvanto K; Eriksson T; Gray P; Apter D; Baussano I; Bly A; Harjula K; Heikkila K; Hokkanen M; Huhtinen L; Ikonen M; Karttunen H; Nummela M; Soderlund-Strand A; Veivo U; Dillner J; Elfstom M; Nieminen P; Lehtinen M
Article: INTERNATIONAL JOURNAL OF CANCER. 2019;145(3):785-796
Occurrence of human papillomavirus (HPV) type replacement by sexual risk-taking behaviour group: Post-hoc analysis of a community randomized clinical trial up to 9 years after vaccination (IV)
Gray P; Luostarinen T; Vanska S; Eriksson T; Lagheden C; Man I; Palmroth J; Pimenoff VN; Soderlund-Strand A; Dillner J; Lehtinen M
Article: INTERNATIONAL JOURNAL OF CANCER. 2018;142(12):2491-2500
Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II)
Gray P; Palmroth J; Luostarinen T; Apter D; Dubin G; Garnett G; Eriksson T; Natunen K; Merikukka M; Pimenoff V; Soderlund-Strand A; Vanska S; Paavonen J; Pukkala E; Dillner J; Lehtinen M

All other publications

Letter: INTERNATIONAL JOURNAL OF CANCER. 2023;153(6):1313-1315
HPV16 E6-antibody associated risk of oropharyngeal cancer increases by calendar-time: A nested case-control study
Lehtinen M; Butt J; Gray P; Brenner N; Eriksson T; Lehtinen T; Luostarinen T; Schroeder L; Surcel H-M; Makitie A; Pimenoff VN; Waterboer T
Editorial comment: EXPERT REVIEW OF VACCINES. 2022;21(6):735-738
In 30 years, gender-neutral vaccination eradicates oncogenic human papillomavirus (HPV) types while screening eliminates HPV-associated cancers
Lehtinen M; Gray P; Louvanto K; Vanska S
Preprint: SSRN ELECTRONIC JOURNAL. 2019
Population-Based Human Papillomavirus Serosurvey Reveals HPV16/18 Herd Effect But No Clear Type-Replacement in Unvaccinated Females 6 Years Post Gender-Neutral Vaccination in a Cluster Randomised Trial
Gray P; Artemchuk H; Pimenoff VN; Eriksson T; Luostarinen T; Vänskä S; Surcel H-M; Faust H; Dillner J; Lehtinen M

Employments

Affiliated to Research, Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 2024-2025
Postdoctoral Studies, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 2023-2025

About me

Articles

All other publications

Employments

News from KI

Events from KI